BROWN RUDNICK LLP for AMNEAL PHARMACEUTICALS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 14, 2014 | $30,000 | Replaced |
| 3rd Quarter - Amendment | Oct 15, 2014 | $30,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); P.L. 110 -85 relating to Risk Evaluation and Mitigation Strategy programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | SPA, Sen John McCain (09-13) |
| LISA LAYMAN | SPA, Sen Stabenow (05-07) |
| HENRY W MENN | CoS, Sen Bob Graham (01-04) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.